PD-166866

CAS No. 192705-79-6

PD-166866( PD166866 | PD166866 | PD 166866 )

Catalog No. M17405 CAS No. 192705-79-6

PD166866 is a selective FGFR tyrosine kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 78 In Stock
25MG 146 In Stock
50MG 289 In Stock
100MG 429 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD-166866
  • Note
    Research use only, not for human use.
  • Brief Description
    PD166866 is a selective FGFR tyrosine kinase inhibitor.
  • Description
    PD166866 is a selective inhibitor of the FGF-1 receptor tyrosine kinase (FGFR1) with IC50 = 55 nM, and no effect on c-Src, PDGFR-b, EGFR or insulin receptor tyrosine kinases or MEK, PKC, and CDK4. PD166866 has clear antiproliferative effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PD166866 | PD166866 | PD 166866
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    OCT
  • Recptor
    FGFR1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    192705-79-6
  • Formula Weight
    396.45
  • Molecular Formula
    C20H24N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 10.33 mg/mL. 26.06 mM;
  • SMILES
    COc1cc(OC)cc(c1)-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C
  • Chemical Name
    1-(2-amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-(tert-butyl)urea.

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Panek RL, et al. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J Pharmacol Exp Ther. 1998 Jul;286(1):569-77.
molnova catalog
related products
  • OAC2

    OAC2 is an Oct4-activating compound which activates expression through the Oct4 gene promoter.

  • CP-91149

    CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.

  • PD-166866

    PD166866 is a selective FGFR tyrosine kinase inhibitor.